Specialty guidance collection

Focused programmes, not one-size-fits-all rules.

Six current Canadian practice areas translated into bounded clinical or quality workflows, each with its limitations kept visible.

ML

Fibrosis risk pathway

MASLD

FIB-4, SWE/TE and MRE risk stratification with technical caveats.
CAR MASLD Parts 1–3Open local draft →
PM

Programme quality

Prostate MRI

Indication, acquisition, reporting and QA guardrails.
CAR white paper · reaffirmed 2026Open local draft →
FM

CT-sparing paediatric MRI

Pediatric FAST MRI

Indication-specific recommendation strength, protocol and limitations.
CAR/CanSPR 2026Open local draft →
BR

Referral and practice

Breast imaging

Screening entry points and modality-role reference.
CAR 2024–2026Open local draft →
DX

Reporting quality

BMD / DXA

Valid-site, limitation and report-transparency checklist without automated diagnosis or treatment.
CAR BMD update · ISCD 2023Open local draft →
LC

Screening is not diagnosis

Lung screening

BC eligibility gate plus CAR/CSTR low-dose CT protocol.
CAR/CSTR · BC Cancer 2026Open local draft →